Catalog Number UNK CDS |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Atrial Fibrillation (1729); Unspecified Infection (1930); Visual Disturbances (2140); Dizziness (2194); Nervous System Injury (2689)
|
Event Date 03/01/2019 |
Event Type
Injury
|
Event Description
|
This is filed to report atrial fibrillation, delirium, stroke, seizures and hallucinations.The aim of this prospective monocentric study is to describe the various neurological complications after cardiac surgery or percutaneous valve replacement and to identify possible risk factors.297 patients with percutaneous valve replacement with a mitraclip procedure or cardiac surgery were postoperatively screened for neurological complications such as delirium, stroke, seizures and hallucinations twice daily for three days.Pre- and perioperative risk factors were evaluated in a multivariate model.The incidence of postoperative delirium after percutaneous valve replacement was between 0% to 44.6%.Patients with percutaneous valve replacement had a similar frequency of postoperative delirium (pod), but no acute ischemic stroke (ais), and no seizures in comparison to patients with cardiac surgery, although the patients with percutaneous valve replacement had a higher preoperative risk profile.Patients with neurological complications had in median significantly longer hospital stays.The median was 7 days for percutaneous valve replacement.A total of 7 patients experienced postoperative atrial fibrillation (af) and 10 patients experience hallucinations.Pod is the most frequent postoperative neurological complication in patients with cardiac surgery or percutaneous valve replacement.The results suggest that patients with neurological complications have a preoperative risk profile including older age, history of heart failure and cognitive impairment.But a complicated intra- and postoperative course with intense inflammatory response and diverse organ dysfunction might be a more important trigger for developing postoperative neurological complications.Details are listed in the attached article titled [e-129176 article], "stroke, seizures, hallucinations and postoperative delirium as neurological complications after cardiac surgery and percutaneous valve replacement.".
|
|
Manufacturer Narrative
|
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported atrial fibrillation (no treatment), the reported nervous system injury (no treatment) / dizziness associated with delirium, the reported visual disturbances associated with hallucinations, the reported infection, and the reported hospitalization or prolonged hospitalization could not be determined.The reported patient effects of atrial fibrillation and infection, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.A2: mean age a3: majority gender b3: date of event was estimated as 01 march 2019.D4: the udi is unknown as the part and lot numbers were not provided d6a: date of implant was estimated as (b)(6) 2019.
|
|
Search Alerts/Recalls
|
|